1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Psychemedics Corporation

Psychemedics Corporation

PMD
Psychemedics CorporationUS flagNASDAQ Capital Market
2.67
USD
+2.67
- -
15.56MMarket Cap

Total Valuation

Psychemedics Corporation carries a market capitalization of 15.56M, placing it among publicly traded companies globally. Its enterprise value stands at 12.83M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap15.56M
Enterprise Value12.83M

Share Statistics

Psychemedics Corporation currently has 6.11M shares outstanding.

Shares Outstanding6.11M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.66, and the price-to-book ratio stands at -0.70.

PE RatioN/A
PS Ratio0.66
PB Ratio-0.70
P/TBV Ratio2.55
P/FCF Ratio12.87
P/OCF Ratio14.08

Enterprise Valuation

On an enterprise value basis, Psychemedics Corporation trades at an EV/EBITDA multiple of 68.24 and an EV/FCF ratio of 12.63.

EV / Sales0.65
EV / EBITDA68.24
EV / EBITN/A
EV / FCF12.63

Financial Position

Psychemedics Corporation maintains a current ratio of 1.82, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

Current Ratio1.82
Quick Ratio1.45
Debt / Equity22.73
Debt / EBITDA6.20
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-18.03
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Income Tax-55,000.00
Effective Tax RateN/A

Stock Price Statistics

Psychemedics Corporation's stock has gained approximately 20.81448% over the past 52 weeks. The 50-day moving average sits at 2.10, while the 200-day moving average is 2.23.

Beta (5Y)N/A
52-Week Price Change20.81448%
50-Day Moving Average2.10
200-Day Moving Average2.23
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Psychemedics Corporation generated 19.69M in revenue and converted that into -1.86M in net income, yielding earnings per share of -0.32. EBITDA reached 188,000.00, while operating income came in at -1.89M.

Revenue19.69M
Gross Profit7.10M
Operating Income-1.89M
Pretax Income-1.92M
Net Income-1.86M
EBITDA188,000.00
EBIT-1.89M
Earnings Per Share (EPS)-0.32

Balance Sheet

Psychemedics Corporation holds 1.42M in cash and equivalents against 1.17M in total debt, resulting in a net debt position of -1.21M. Total book value stands at -18.60M, with working capital of 2.23M providing operational flexibility.

Cash & Cash Equivalents1.42M
Total Debt1.17M
Net Debt-1.21M
Equity (Book Value)-18.60M
Book Value Per Share-3.19
Working Capital2.23M

Cash Flow

Psychemedics Corporation produced 929,000.00 in operating cash flow over the past twelve months. After subtracting -87,000.00 in capital expenditures, free cash flow totaled 842,000.00 - equivalent to 0.14 per share.

Operating Cash Flow929,000.00
Capital Expenditures-87,000.00
Free Cash Flow842,000.00
FCF Per Share0.14

Margins

Psychemedics Corporation operates with a gross margin of 36.07, reflecting its pricing power and cost economics. The operating margin of -9.62 and net profit margin of -9.45 provide insight into operational efficiency.

Gross Margin36.07
Operating Margin-9.62
Pretax Margin-9.73
Profit Margin-9.45
EBITDA Margin0.96

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield10.62
FCF Yield7.77

Stock Splits

Psychemedics Corporation's most recent stock split took place on August 1, 2002 with a 4:1 split ratio.

Last Split Date8/1/2002
Split Ratio4:1

Scores

Psychemedics Corporation posts an Altman Z-Score of 1.26, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.26